Email
Print
The Glutamine Market size is projected to grow at a CAGR of 2.4% during the forecast period 2022-2027 and reach US$161.4 million by 2027. The growth of the glutamine market is
primarily dependent on the growth of the pharmaceutical sector. Glutamine is an amino acid and a derivative of
glutamic acid. They can be categorized into L-glutamine and D-glutamine and is
used in various end-uses such as pharmaceutical, dietary supplement, cosmetics
& personal care and others. Glutamine is mainly used in the production
of medicines and pharmaceutical products for treating sickle cell disease,
irritable bowel syndrome, abdominal pain and other conditions. It also plays a
significant role in improving a body’s immunity function and wound-healing
capability after surgery. The surging developments associated with the pharmaceutical
sector have led to considerable growth in the Glutamine market.
Glutamine Market: The Pharmaceutical Segment Leads the Market
On the basis of the end-user, the Glutamine Market can be segmented into pharmaceuticals, cosmetics & personal care, dietary supplement and others. The pharmaceutical sector is evaluated to be the leading segment in the glutamine market in 2021. During the forecast period 2022-2027, the pharmaceutical segment is expected to grow at a CAGR of 2.8%. This can be attributed to various factors such as the increasing production of pharmaceutical products across the world. According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), global pharmaceutical production was valued at US$354,822 million in 2021, representing an increase of 4.6% from US$339,088 million in 2020. Moreover, according to Vietnam’s Ministry of Health, the pharmaceutical industry is expected to grow at a rate of 10% per year from 2017 to 2028, owing to an increase in pharmaceutical production and sales in the country.
For More Queries About "Glutamine Market" @ https://www.industryarc.com/support.php?id=17732
Glutamine
Market: North America Holds the Largest Share
On the basis of geography, the Glutamine
Market can be segmented into North America, South America, Europe, APAC and
EMEA. According to IndustryARC’s analysis, North America has emerged as the
most dominant region in the market. In 2021, the North American region held over 35% share of the total revenue earned by the market globally. North
American countries including the USA and Canada are comparatively ahead in terms of
the growth of the pharmaceutical sector. In 2021, the government
of Canada invested more than US$1 billion in the development and growth of the
pharmaceutical sector in the country.
The glutamine market would also witness significant
growth in the Asia-Pacific region. China and India are emerging as competitive
countries in the Glutamine market. According to the India
Brand Equity Foundation (IBEF), India ranked 3rd in terms of pharmaceutical
production by volume in 2021. It further states that the domestic
pharmaceutical industry in India includes around 3,000 drug companies and
approximately 10,500 manufacturing units.
Glutamine
Market: Competitive Landscape
Key companies holding major shares in the Glutamine Market are Ajinomoto Co., Inc., Evonik, Optimum Nutrition Inc., Nutritech, NOW Foods, Dymatize Enterprises LLC, Allmax Nutrition Inc., Nutri Advanced Ltd., Battery Nutrition Limited and Kyowa Hakko Kirin Co., Ltd.
To request for a quote, provide your details in the below link:
https://www.industryarc.com/reports/request-quote?id=17732